Biophotonics is the study of optical processes in biological systems, both those that occur naturally and in bioengineered materials. A particularly important aspect of this field is imaging and sensing cells and tissue. This includes injecting fluorescent markers into a biological system to track cell dynamics and drug delivery. Furthermore, biophotonics has many applications in the fields of medicine, genetics, biology, agriculture and environmental science.
According to this analysis, the Global Biophotonics Market was valued at ~US$ 30 billion in 2017. Furthermore, owing to the development in biosensors and increased use of biophotonics in the nonmedical sector, it is estimated to be ~US$ 50 billion in 2022 and is expected to reach a market size of ~US$ 100 billion by 2028 growing with a CAGR of ~12% during 2022 to 2028.
The recent surge of nanotechnology, combined with increasing demand for home-based Point-of-Care (POC) devices, is expected to drive market growth in the coming years.
Advances in optical technologies in the aerospace and telecommunications sectors, combined with the availability of private and government funds for R&D, are also expected to boost the market growth.
The complexity of biophotonics technology, combined with the high cost of biophotonics-based instruments, may stifle market growth.
The ongoing COVID-19 pandemic has hampered biophotonics market growth by disrupting hospital care for non-COVID-19 patients in hospitals and other end-user facilities across countries.
By End-User: The Medical Diagnostics segment held the largest market share of the global biophotonics market in 2021.
Diagnostic biophotonics is used to detect diseases in their initial stages before actual medical symptoms occur in patients.
Furthermore, they provide several advantages of sensing and imaging at the molecular level and also collect multidimensional data for evaluation.
By Application: The Analytical Sensing segment held the largest market share of the global biophotonics market in 2021.
It is a two-part analytic device that consists of two major components: a (bio) chemical microzone (recognition element) that comes into contact with the sample and is closely associated (connected or integrated) with an optical, electric, thermal, mass, or acoustic transducer for converting the recognition pattern into a (usually electric or optical) primary signal that can be amplified and measured by a detector (instrument).
Furthermore, they typically respond to the presence and/or concentration (activity) of an analyte species.
By Geography: North America accounts for the largest share among all regions within the Global Biophotonics market.
Rapid advancements in the development and adoption of digital health technologies (DHT) across North America, notably in the United States, are one of the major contributing factors to the growth of biophotonics.
Increasing regional government initiatives and strategies, favorable healthcare infrastructure, increased investment in R&D activities to develop the industry, and regulatory science activities across the healthcare industry are also propelling the biophotonics market growth in North America.
Country-Niche players comprise about ~50% of the competitors, while regional players hold a share of ~30%. Some of the major players in the market include Affymetrix Inc., Andor Technology, BD (Becton, Dickinson and Company), Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Zecotek Photonic Inc., Idex Corporation, IPG Photonics, Oxford Instruments Plc., and among others.
Note: This is an On-Demand/Planned report, so the figures quoted here for a market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and the report delivered within a maximum of 2 working weeks.
According to this analysis, the Global Biophotonics Market was valued at ~US$ 30 billion in 2017. Furthermore, owing to the development in biosensors and increased use of biophotonics in the nonmedical sector, it is estimated to be ~US$ 50 billion in 2022 and is expected to reach a market size of ~US$ 100 billion by 2028 growing with a CAGR of ~12% during 2022 to 2028.
The recent surge of nanotechnology, combined with increasing demand for home-based Point-of-Care (POC) devices, is expected to drive market growth in the coming years.
Advances in optical technologies in the aerospace and telecommunications sectors, combined with the availability of private and government funds for R&D, are also expected to boost the market growth.
The complexity of biophotonics technology, combined with the high cost of biophotonics-based instruments, may stifle market growth.
The ongoing COVID-19 pandemic has hampered biophotonics market growth by disrupting hospital care for non-COVID-19 patients in hospitals and other end-user facilities across countries.
Scope of the Report
The Global Biophotonics Market is segmented by technology, end-user, and application. In addition, the report also covers market size and forecasts for the four major regions in the stem cell banking Market. The revenue used to size and forecast the market for each segment is US$ billion.By Technology
- In-Vivo
- In-Vitro
By End User
- Tests and Components
- Medical Therapeutics
- Medical Diagnostics
- Non-Medical Application
By Application
- Surface Imaging
- Inside Imaging
- See-through Imaging
- Microscopy
- Bio Sensors
- Analytical Sensing
- Spectromolecular
- Others
By Region
- North America (USA, Canada, and Mexico)
- Europe (France, Italy, Germany, Spain, UK, and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, and Rest of Asia Pacific)
- LAMEA (Latin America, Middle East, and Africa)
Key Players
- Affymetrix Inc
- Andor Technology
- BD (Becton, Dickinson and Company)
- Carl Zeiss AG
- Olympus Corporation
- Hamamatsu Photonics KK
- Zecotek Photonic Inc
- Idex Corporation
- IPG Photonics
- Oxford Instruments Plc
Key Trends by Market Segment
- By Technology: The In-Vitro segment held the largest market share of the global biophotonics market in 2021
- In-Vitro basically used studying cells in culture or methods of testing the antibiotic sensitivity of bacteria
By End-User: The Medical Diagnostics segment held the largest market share of the global biophotonics market in 2021.
Diagnostic biophotonics is used to detect diseases in their initial stages before actual medical symptoms occur in patients.
Furthermore, they provide several advantages of sensing and imaging at the molecular level and also collect multidimensional data for evaluation.
By Application: The Analytical Sensing segment held the largest market share of the global biophotonics market in 2021.
It is a two-part analytic device that consists of two major components: a (bio) chemical microzone (recognition element) that comes into contact with the sample and is closely associated (connected or integrated) with an optical, electric, thermal, mass, or acoustic transducer for converting the recognition pattern into a (usually electric or optical) primary signal that can be amplified and measured by a detector (instrument).
Furthermore, they typically respond to the presence and/or concentration (activity) of an analyte species.
By Geography: North America accounts for the largest share among all regions within the Global Biophotonics market.
Rapid advancements in the development and adoption of digital health technologies (DHT) across North America, notably in the United States, are one of the major contributing factors to the growth of biophotonics.
Increasing regional government initiatives and strategies, favorable healthcare infrastructure, increased investment in R&D activities to develop the industry, and regulatory science activities across the healthcare industry are also propelling the biophotonics market growth in North America.
Competitive Landscape
The Global Biophotonics market is highly competitive with ~200 players which include globally diversified players, regional players as well as a large number of country-niche players each with their niche in pharma and diagnostics solutions, and technologies, such as vitro analyses of DNA variation, RNA expression, metabolite quantification, vivo measurements of biological processes, and others, for end-user industries. The biophotonics market's growth is heavily reliant on technological advancement and R&D investment. Nowadays, numerous pharmaceutical companies are investing in R&D or drug research, and governments are also making significant investments in cancer research.Country-Niche players comprise about ~50% of the competitors, while regional players hold a share of ~30%. Some of the major players in the market include Affymetrix Inc., Andor Technology, BD (Becton, Dickinson and Company), Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Zecotek Photonic Inc., Idex Corporation, IPG Photonics, Oxford Instruments Plc., and among others.
Conclusion
The Global Biophotonics Market is forecasted to continue an rapid growth that is witnessed since 2019, during the forecast period also, primarily driven by the emergence of applied science, important technological advancements over a few years, and their adoption in the medical sector. Though the market is highly competitive with over ~200 participants, few country-niche players control the dominant share.Note: This is an On-Demand/Planned report, so the figures quoted here for a market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and the report delivered within a maximum of 2 working weeks.
Key Topics Covered in the Report
- Snapshot of Global Biophotonics Market
- Industry Value Chain and Ecosystem Analysis
- Market size and Segmentation of Global Biophotonics Market
- Historic Growth of Overall Global Biophotonics Market and Segments
- Competition Scenario of the Market and Key Developments of Competitors
- Porter’s 5 Forces Analysis of Global Biophotonics Industry
- Overview, Product Offerings, and SWOT Analysis of Key Competitors
- Covid-19 Impact on the Overall Global Biophotonics Market
- Future Market Forecast and Growth Rates of the Total Global Biophotonics Market and by Segments
- Market Size of Application/End User Segments with Historical CAGR and Future Forecasts
- Analysis of Global Biophotonics Market
- Major Production/Supply and Consumption/Demand Hubs within Each Region
- Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
- Overview of Notable Emerging Competitor Companies within Each Region
Major Companies Mentioned in the Report
- Affymetrix Inc
- Andor Technology
- BD (Becton, Dickinson and Company)
- Carl Zeiss AG
- Olympus Corporation
- Hamamatsu Photonics KK
- Zecotek Photonic Inc
- Idex Corporation
- IPG Photonics
- Oxford Instruments Plc
- Lumicks
- Creoptix
- ThnikCyte
- PhotoPharmics
- Impedimed
- Norlase
- Vivosight
- Speclipse
Key Target Audience - Organizations and Entities Who Can Benefit by Subscribing This Report
- Biotechnology - Therapeutics and Diagnostics Companies
- Pharmaceutical Companies
- Manufacturers of Diagnostic Kits and Instruments
- International Agency for Research on Cancer (IARC)
- Neural Regeneration Research Organizations
- Research Drug Monitoring Authorities
- AI Solution Providers for Drug Discovery
- Medical Devices manufacturers
- Government Ministries and Departments of Healthcare
Period Captured in the Report
- Historical Period: 2017-2021
- Forecast Period: 2022-2028F
Frequently Asked Questions
What is the Study Period of this Market Report?- The Global Biophotonics Market is covered from 2017-2028 in this report, which includes a forecast for the period 2022-2028
- The Global Biophotonics Market is expected to witness a CAGR of about 12% over the next 6 years
- Advances in optical technologies in the aerospace and telecommunications sectors, combined with the availability of private and government funds for R&D are expected to be the primary drivers of this market
- The analytical sensing segment holds the largest share of the Global Biophotonics Market
- Affymetrix Inc., Andor Technology, BD (Becton, Dickinson and Company), Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Zecotek Photonic Inc., Idex Corporation, IPG Photonics, Oxford Instruments Plc., among others are the major companies operating in Global Biophotonics Market
Additional benefits of purchasing an enterprise license:
- TAM/SAM/SOM Analysis
- Customer Cohort Analysis
- Marketing Initiatives
- White Space Opportunity Analysis
- Interactive Data Visualizations
- Customization: 20 Analyst Hours
- 3 Months Post Sales Analyst Support
- Complimentary Update Next Year
- Custom Webinars
Table of Contents
1. Executive Summary
2. Market Overview and Key Trends Impacting Growth
3. Global - Market Segmentation by Type, Historic Growth, Outlook & Forecasts
4. Global - Market Segmentation by End-User, Historic Growth, Outlook & Forecasts
5. Global - Market Segmentation by Application, Historic Growth, Outlook & Forecasts
6. Industry/Competition Analysis - Competitive Landscape
7. Key Competitor Profiles (Company Overview, Product Offerings, SWOT Analysis)
8. Geographic Analysis & Major Countries Market Historic Growth, Outlook, and Forecasts
9. Industry Expert’s Opinions/Perspectives
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affymetrix Inc.
- Andor Technology
- BD (Becton, Dickinson and Company)
- Carl Zeiss AG
- Olympus Corporation
- Hamamatsu Photonics K.K
- Zecotek Photonic Inc.
- Idex Corporation
- IPG Photonics
- Oxford Instruments Plc
- Lumicks
- Creoptix
- ThnikCyte
- PhotoPharmics
- Impedimed
- Norlase
- Vivosight
- Speclipse
